AdaptHealth Corp. (AHCO): Price and Financial Metrics

AdaptHealth Corp. (AHCO): $21.40

0.07 (+0.33%)

POWR Rating

Component Grades














  • Growth is the dimension where AHCO ranks best; there it ranks ahead of 80.75% of US stocks.
  • The strongest trend for AHCO is in Stability, which has been heading up over the past 177 days.
  • AHCO ranks lowest in Sentiment; there it ranks in the 12th percentile.

AHCO Stock Summary

  • For AHCO, its debt to operating expenses ratio is greater than that reported by 92.61% of US equities we're observing.
  • In terms of twelve month growth in earnings before interest and taxes, ADAPTHEALTH CORP is reporting a growth rate of 270.39%; that's higher than 93.82% of US stocks.
  • As for revenue growth, note that AHCO's revenue has grown 37.68% over the past 12 months; that beats the revenue growth of 77.98% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to ADAPTHEALTH CORP, a group of peers worth examining would be VIRT, ERO, SPH, TROX, and FPI.
  • Visit AHCO's SEC page to see the company's official filings. To visit the company's web site, go to

AHCO Valuation Summary

  • AHCO's price/sales ratio is 1; this is 52.38% lower than that of the median Healthcare stock.
  • AHCO's price/earnings ratio has moved down 2.4 over the prior 60 months.

Below are key valuation metrics over time for AHCO.

Stock Date P/S P/B P/E EV/EBIT
AHCO 2023-01-30 1 1.3 29.9 22.0
AHCO 2023-01-27 1 1.3 30.1 22.1
AHCO 2023-01-26 1 1.3 30.2 22.1
AHCO 2023-01-25 1 1.3 29.7 22.0
AHCO 2023-01-24 1 1.3 29.5 21.9
AHCO 2023-01-23 1 1.3 30.4 22.2

AHCO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AHCO has a Quality Grade of D, ranking ahead of 14.88% of graded US stocks.
  • AHCO's asset turnover comes in at 0.551 -- ranking 48th of 81 Healthcare stocks.
  • LFMD, RHE, and ENSG are the stocks whose asset turnover ratios are most correlated with AHCO.

The table below shows AHCO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.551 0.179 -0.015
2021-03-31 0.625 0.162 -0.109
2020-12-31 0.887 0.149 -0.185
2020-12-31 0.887 0.149 -0.049
2020-09-30 1.416 0.155 0.096
2020-06-30 1.730 0.156 0.105

AHCO Price Target

For more insight on analysts targets of AHCO, see our AHCO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $42.25 Average Broker Recommendation 1.2 (Strong Buy)

AHCO Stock Price Chart Interactive Chart >

Price chart for AHCO

AHCO Price/Volume Stats

Current price $21.40 52-week high $27.48
Prev. close $21.33 52-week low $11.40
Day low $20.87 Volume 544,500
Day high $21.64 Avg. volume 618,991
50-day MA $20.81 Dividend yield N/A
200-day MA $19.72 Market Cap 2.88B

AdaptHealth Corp. (AHCO) Company Bio

AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

AHCO Latest News Stream

Event/Time News Detail
Loading, please wait...

AHCO Latest Social Stream

Loading social stream, please wait...

View Full AHCO Social Stream

Latest AHCO News From Around the Web

Below are the latest news stories about ADAPTHEALTH CORP that investors may wish to consider to help them evaluate AHCO as an investment opportunity.

AdaptHealth up 1.5%, guides FY revenue above consensus

  • AdaptHealth (NASDAQ:AHCOexpects FY 2023 net revenue of $3.21B-3.29B; Adjusted EBITDA of $690M-750M; and total capital expenditures are expected to be 9-11% of net revenue.

  • For the FY 2022, net revenue expected to be near the midpoint of the previously-provided guidance range of $2.95B-3.01B (Seeking Alpha | January 11, 2023

AdaptHealth sees FY22 revenue near midpoint of prior guidance; initiates FY23 guidance

  • AdaptHealth (NASDAQ:AHCO) is up 1.5% after-hours after the firm has provided its initial guidance for FY 2023 and preliminary commentary on Q4 2022 results.
  • For the full year 2022, the company anticipates net revenue to be near the midpoint of the previously-provided guidance range of $2.950 billion to $3.010 billion vs. consensus of $2.98B and Adjusted EBITDA to be n...

    Seeking Alpha | January 11, 2023

AdaptHealth Stock Shows Improved Relative Strength Rating

A Relative Strength Rating upgrade for AdaptHealth shows improving technical performance. Will it continue?

Yahoo | January 11, 2023

AdaptHealth Provides Full-Year 2023 Guidance and Preliminary Commentary on Fourth Quarter 2022 Results

PLYMOUTH MEETING, Pa., January 11, 2023--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, today provided its initial guidance for full-year 2023 and preliminary commentary on fourth quarter 2022 results.

Yahoo | January 11, 2023

Should We Be Cautious About AdaptHealth Corp.'s (NASDAQ:AHCO) ROE Of 4.5%?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Yahoo | January 10, 2023

Read More 'AHCO' Stories Here

AHCO Price Returns

1-mo 8.91%
3-mo 1.61%
6-mo -3.78%
1-year 25.07%
3-year 34.17%
5-year N/A
YTD 11.34%
2022 -21.42%
2021 -34.88%
2020 242.08%
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7596 seconds.